Examination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platforms

Abstract Background Plasma biomarkers like Aβ42/Aβ40, p ‐tau isoforms, and NfL are crucial for assessing Alzheimer's disease (AD) pathology. Advanced platforms such as SomaScan 11k, Olink 5k, and ALAMAR (NULISA‐based) enable precise protein measurement. We examined associations between Alamar's NULISA proteins related to AD (ATN & I) with SomaScan and Olink proteins and conducted pathway enrichment analysis to identify proteomic profiles linked to AD biomarkers. Method This cross‐sectional study used plasma samples from 116 ARIC cohort participants (age 74.3 ± 4.7 years, 88.8% cognitively normal). ATN & I biomarkers included: A (Aβ proteinopathy) – Aβ‐42, Aβ‐40, and Aβ‐42/40; T (phosphorylated and secreted AD tau) ‐ p ‐tau217, p ‐tau181, p ‐tau231 and their ratios with Aβ‐42; N (neuropil injury) – NfL and Total Tau; and I (inflammation) – GFAP. Biomarkers were quantified using the ALAMAR NULISA platform and compared to SomaScan 11k and Olink 5k data. Cross‐platform correlations and pathway enrichment analyses (KEGG library) were conducted. Bonferroni correction adjusted for multiple comparisons, and analyses were adjusted for age, sex, APOE ε4 status, and glomerular filtration rate. Result There were 3,418 proteins (92 with unique IDs) across SomaScan, Olink, and NULISA platforms. Aβ42 had the most intersecting proteins (268), NEFL had 146, and GFAP had 57. Between Alamar and Olink, Aβ40 had 456 significantly correlated proteins, NEFL had 379, and Aβ42 had 359 after Bonferroni adjustment ( p < .00001). Between Alamar and SomaScan, Aβ40 had 408 and Aβ42 had 351 significantly correlated proteins ( p < .00001). In Olink pathway enrichment, Aβ42/40 had the most correlated pathways, while in SomaScan, Ptau231 had the most. Common pathways included cytokine‐cytokine interaction, insulin signaling, MAPK signaling, cell adhesion, and endocytosis. Conclusion Our analysis identified shared proteomic profiles associated with AD biomarkers across multiple proteomic platforms. The Alamar ATN & I plasma biomarkers demonstrated moderate to strong correlations with Olink 5k and Soma 11k proteins subserving muscular integrity, inflammation, kidney function, cell membrane integrity, fatty acid degradation. Cytokine‐cytokines and axonal pathways were among the highest correlated pathways among the ATN & I biomarkers across Olink and Soma platforms. Future investigations should examine tissue specific pathways in older individuals across the AD continuum.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_106888
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Examination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platforms

Hubert Leo, Omonigho M. Bubu, Joshua L. Gills, The ARIC Neurocognitive Biomarker Workgroup
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Examination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platforms

Hubert Leo, Omonigho M. Bubu, Joshua L. Gills, The ARIC Neurocognitive Biomarker Workgroup
article en

Abstract

Abstract Background Plasma biomarkers like Aβ42/Aβ40, p ‐tau isoforms, and NfL are crucial for assessing Alzheimer's disease (AD) pathology. Advanced platforms such as SomaScan 11k, Olink 5k, and ALAMAR (NULISA‐based) enable precise protein measurement. We examined associations between Alamar's NULISA proteins related to AD (ATN & I) with SomaScan and Olink proteins and conducted pathway enrichment analysis to identify proteomic profiles linked to AD biomarkers. Method This cross‐sectional study used plasma samples from 116 ARIC cohort participants (age 74.3 ± 4.7 years, 88.8% cognitively normal). ATN & I biomarkers included: A (Aβ proteinopathy) – Aβ‐42, Aβ‐40, and Aβ‐42/40; T (phosphorylated and secreted AD tau) ‐ p ‐tau217, p ‐tau181, p ‐tau231 and their ratios with Aβ‐42; N (neuropil injury) – NfL and Total Tau; and I (inflammation) – GFAP. Biomarkers were quantified using the ALAMAR NULISA platform and compared to SomaScan 11k and Olink 5k data. Cross‐platform correlations and pathway enrichment analyses (KEGG library) were conducted. Bonferroni correction adjusted for multiple comparisons, and analyses were adjusted for age, sex, APOE ε4 status, and glomerular filtration rate. Result There were 3,418 proteins (92 with unique IDs) across SomaScan, Olink, and NULISA platforms. Aβ42 had the most intersecting proteins (268), NEFL had 146, and GFAP had 57. Between Alamar and Olink, Aβ40 had 456 significantly correlated proteins, NEFL had 379, and Aβ42 had 359 after Bonferroni adjustment ( p < .00001). Between Alamar and SomaScan, Aβ40 had 408 and Aβ42 had 351 significantly correlated proteins ( p < .00001). In Olink pathway enrichment, Aβ42/40 had the most correlated pathways, while in SomaScan, Ptau231 had the most. Common pathways included cytokine‐cytokine interaction, insulin signaling, MAPK signaling, cell adhesion, and endocytosis. Conclusion Our analysis identified shared proteomic profiles associated with AD biomarkers across multiple proteomic platforms. The Alamar ATN & I plasma biomarkers demonstrated moderate to strong correlations with Olink 5k and Soma 11k proteins subserving muscular integrity, inflammation, kidney function, cell membrane integrity, fatty acid degradation. Cytokine‐cytokines and axonal pathways were among the highest correlated pathways among the ATN & I biomarkers across Olink and Soma platforms. Future investigations should examine tissue specific pathways in older individuals across the AD continuum.

Alzheimer s & DementiaVol. 21(S2)
NYU Langone Health (US), New York University (US)
Good health and well-being
Openalex Percentile: Top 31%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.